8 results on '"Hambly, R."'
Search Results
2. 121 Mass Spectrometry-based Proteome Analysis of Skin Microdialysates
- Author
-
Beizaei, A., primary, Gatault, S., additional, Rea, H., additional, Hambly, R., additional, Kearns, S., additional, Lynam-Loane, K., additional, Kirby, B., additional, Kolch, W., additional, and Ebhardt, A.H., additional
- Published
- 2019
- Full Text
- View/download PDF
3. Influence of diets containing high and low risk factors for colon cancer on early stages of carcinogenesis in human flora-associated (HFA) rats
- Author
-
Hambly, R., primary
- Published
- 1997
- Full Text
- View/download PDF
4. Genotoxic activity in human faecal water and the role of bile acids: a study using the alkaline comet assay.
- Author
-
Venturi, M, Hambly, R J, Glinghammar, B, Rafter, J J, and Rowland, I R
- Abstract
Human faecal waters from 35 healthy non-smoking volunteers (23 from England and 12 from Sweden) consuming their habitual diet were screened for genotoxicity by the single-cell gel electrophoresis (comet) assay using a human colon adenocarcinoma cell line (CACO-2) as the target. Hydrogen peroxide induced DNA damage was categorized as low, intermediate or high for tail moments greater than 5, 17 and 32, respectively: 11 samples were highly genotoxic, four were intermediate, one was low and 19 showed no activity. Endonuclease III treatment significantly increased DNA damage for all except the non-genotoxic faecal waters, suggesting that faecal water genotoxicity may be due, at least in part, to oxidative damage. Faecal water cytotoxicity has previously been attributed to the bile and fatty acid content. In the comet assay no DNA damage was induced by deoxycholate or lithocholate at normal physiological concentrations, suggesting that the genotoxicity of faecal water was due to other substances. Both bile acids induced DNA damage above 300 microM, levels often found in patients with colonic polyps and there was a significant increase in genotoxicity after endonuclease III treatment indicative of oxidative DNA damage. [ABSTRACT FROM PUBLISHER]
- Published
- 1997
- Full Text
- View/download PDF
5. Metformin Treatment of Hidradenitis Suppurativa: Effect on Metabolic Parameters, Inflammation, Cardiovascular Risk Biomarkers, and Immune Mediators.
- Author
-
Hambly R, Kearney N, Hughes R, Fletcher JM, and Kirby B
- Subjects
- Humans, Case-Control Studies, Quality of Life, Risk Factors, Inflammation drug therapy, Biomarkers, C-Reactive Protein metabolism, Immunologic Factors, Heart Disease Risk Factors, Adipokines, Hidradenitis Suppurativa drug therapy, Metformin pharmacology, Metformin therapeutic use, Insulin Resistance, Cardiovascular Diseases etiology, Metabolic Syndrome
- Abstract
Hidradenitis suppurativa (HS) is a common cutaneous and systemic inflammatory disease with a significant impact on mental health and quality of life. It is associated with obesity, insulin resistance, metabolic syndrome, cardiovascular (CV) disease, and increased all-cause mortality. Metformin is used frequently in HS treatment and is effective for some patients. The mechanism of action of metformin in HS is unknown. A case-control study of 40 patients with HS (20 on metformin and 20 controls) was conducted to assess differences in metabolic markers, inflammation (C-reactive protein [CRP], serum adipokines, and CV risk biomarkers), and serum immune mediators. Body mass index (BMI), insulin resistance (77%), and metabolic syndrome (44%) were high overall, but not significantly different between the groups. This highlights the need for co-morbidity screening and management. A significant reduction in fasting insulin and a trend towards a reduction in insulin resistance were identified in the metformin group compared with pre-treatment levels. CV risk biomarkers were significantly favourable in the metformin group (lymphocytes, monocyte-lymphocyte ratio, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio). CRP was lower in the metformin group but was not statistically significant. Adipokines were dysregulated overall but were not different between the two groups. Serum IFN-γ, IL-8, TNF-α, and CXCL1 trended lower in the metformin group but did not reach significance. These results suggest that metformin improves CV risk biomarkers and insulin resistance in patients with HS. When the results of this study are considered alongside other studies in HS and related conditions, it is likely that metformin also has beneficial effects on metabolic markers and systemic inflammation in HS (CRP, serum adipokines, and immune mediators), warranting further research.
- Published
- 2023
- Full Text
- View/download PDF
6. Innate lymphoid cell (ILC) subsets are enriched in the skin of patients with hidradenitis suppurativa.
- Author
-
Petrasca A, Hambly R, Molloy O, Kearns S, Moran B, Smith CM, Hughes R, O'Donnell M, Zaborowski A, Winter D, Fletcher JM, Kirby B, and Malara A
- Subjects
- Humans, Lymphocytes, Leukocytes, Mononuclear, Tumor Necrosis Factor Inhibitors, Inflammation, Immunity, Innate, Hidradenitis Suppurativa
- Abstract
Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory skin disease manifested as painful inflamed lesions including deep-seated nodules, abscesses and sinus tracts. The exact aetiology of HS is unclear. Recent evidence suggests that immune dysregulation plays a crucial role in pathogenesis and disease progression. Innate lymphoid cells (ILC) are a recently identified immune cell subset involved in mediating immunity, however their role in HS has not yet been investigated. Three distinct subsets of ILC- ILC1, ILC2 and ILC3 have been described, and these are involved in skin tissue homeostasis and pathologic inflammation associated with autoimmunity and allergic diseases. In this study, we analysed by multiparameter flow cytometry the frequencies of ILC subsets in skin and peripheral blood mononuclear cells (PBMC) of HS patients and compared these to healthy control subjects and psoriasis patients. The absolute numbers of total ILC and subsets thereof were significantly reduced in the blood of HS patients relative to healthy controls. However, when patients were stratified according to treatment, this reduction was no longer observed in patients undergoing anti-TNF treatment. In HS lesional skin the absolute numbers of ILC were significantly increased relative to control skin. Furthermore, the frequencies of total ILC as well as ILC2 and ILC3 were significantly higher in non-lesional than lesional HS skin. This study analysed for the first time the presence of ILC subsets in the blood and skin of HS patients. Our findings suggest that ILC may participate in HS pathogenesis., Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: RHa received support for attendance at meetings from AbbVie and Janssen. OM received support for attendance at meetings from Novartis. BM received support for attendance at meetings from Miltenyi. AM received support for attendance at meeting from AbbVie. BK has received research support/principal investigator (clinical trials) from AbbVie, Alimirall, Janssen, Merck Sharpe Dolme, Moonlake, Novartis,Pfizer and UCB; been a consultant for AbbVie, Amgen, Almirall, Cel-gene, Janssen, Merck Sharpe Dolme, Moonlake, Novartis, Pfizer and UCB; received honoraria from AbbVie, Amgen, Alimrall, Celgene, Janssen, Lilly, Moonlake, Novartis, Pfizer and UCB; and been on scientific advisory boards for AbbVie, Almirall, Celgene, Janssen, Lilly, Moonlake Novartis, Pfizer and UCB. This does not alter our adherence to PLOS ONE policies on sharing data and materials., (Copyright: © 2023 Petrasca et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
7. Naturally derived Heme-Oxygenase 1 inducers attenuate inflammatory responses in human dendritic cells and T cells: relevance for psoriasis treatment.
- Author
-
Campbell NK, Fitzgerald HK, Malara A, Hambly R, Sweeney CM, Kirby B, Fletcher JM, and Dunne A
- Subjects
- Anti-Inflammatory Agents, Non-Steroidal pharmacology, Carbon Monoxide metabolism, Cell Differentiation, Cell Proliferation, Dendritic Cells drug effects, Enzyme Activation, Gene Expression Regulation, Enzymologic, Humans, Inflammation enzymology, Inflammation immunology, Leukocytes, Mononuclear drug effects, Leukocytes, Mononuclear immunology, Lymphocyte Activation, Psoriasis enzymology, Psoriasis immunology, T-Lymphocytes drug effects, Abietanes pharmacology, Curcumin pharmacology, Dendritic Cells immunology, Heme Oxygenase-1 metabolism, Inflammation prevention & control, Psoriasis drug therapy, T-Lymphocytes immunology
- Abstract
Psoriasis is a chronic autoimmune disease mediated by dysregulated immune responses in dendritic cells (DC) and T cells. The stress-response enzyme heme oxygenase-1 (HO-1) has been described as protective in animal models of psoriasis, however, implementation of HO-1-based therapies is hindered by the lack of clinically-suitable HO-1 inducers. The plant-derived polyphenols, carnosol and curcumin, have been identified as candidate HO-1 inducers however there has been little investigation into their effects on human immune cells. We demonstrate that treatment of human DC with these polyphenols limits DC maturation, reduces pro-inflammatory cytokine production, and prevents induction of allospecific T cell responses, in a manner partially dependent on carbon monoxide (CO). We also characterised their effects in ex-vivo psoriasis PBMC and report that curcumin, but not carnosol, strongly reduces T cell proliferation and cytokine poly-functionality, with reduced expression of psoriatic cytokines IFNγ, IL-17, GM-CSF and IL-22. This study therefore supports reports highlighting the therapeutic potential of curcumin in psoriasis by providing insight into its immunological effects on healthy human DC and psoriasis PBMC. We also demonstrate, for the first time, the anti-inflammatory effects of carnosol in human immune cells.
- Published
- 2018
- Full Text
- View/download PDF
8. Influence of dietary components associated with high or low risk of colon cancer on apoptosis in the rat colon.
- Author
-
Hambly RJ, Saunders M, Rijken PJ, and Rowland IR
- Subjects
- Animals, Body Weight physiology, Colonic Neoplasms epidemiology, DNA chemistry, Rats, Rats, Sprague-Dawley, Risk Factors, Apoptosis physiology, Colon cytology, Colon pathology, Colonic Neoplasms pathology, Diet
- Abstract
Although there is much epidemiological evidence for an interaction between diet and colorectal cancer risk, the mechanisms by which diet might protect against colorectal cancer are still unclear. Here we report the significant up-regulation of carcinogen-induced apoptosis in the colon of rats fed a diet containing low-risk factors for colon cancer, namely low fat content, high calcium and high non-digestible carbohydrate. The dose-dependent induction of apoptosis in colonic crypts by the carcinogen 1,2-dimethylhydrazine (DMH) was significantly greater in rats receiving the low-risk compared with a high-risk (high fat, low calcium, low non-digestible carbohydrate) diet (P<0.001). There were also significant interactions of colon region with DMH dose and region by diet, with the greatest increases in apoptosis occurring in the mid and distal regions of the colon compared with the proximal region. Since we have previously shown the low-risk diet to be non-toxic, these new results suggest a diet-induced up-regulation of apoptosis, which may represent a mechanism of protection against the early stages of carcinogenesis in the colon.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.